US CDC continues to recommend Covid-19 vaccines for children, contradicts Kennedy, World News
The US Centres for Disease Control and Prevention said Covid-19 vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Health Secretary Robert F. Kennedy Jr.'s announcement that the agency would remove the shots from its immunization schedule.
In a schedule published late on Thursday (May 27), the CDC said any Covid-19 vaccination in healthy children aged 6 months to 17 years should follow "shared clinical decision-making" between a child's parents and their healthcare provider.
It had previously recommended updated Covid-19 vaccines for everyone aged six months and older, following the guidance of its panel of outside experts.
"Where the parent presents with a desire for their child to be vaccinated, children 6 months and older may receive Covid-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances," the CDC notice said. It provides instructions for administering the shots to healthy children by age group, from infants to teenagers.
Kennedy, a long-time vaccine skeptic who oversees the CDC, the Food and Drug Administration and the National Institutes of Health, had said on Tuesday the recommendations would be dropped.
"As of today, the Covid-19 vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule," Kennedy said in a video posted on the X platform.
A spokesperson for the Department of Health and Human Services said there was no contradiction between Kennedy's statement and the CDC schedule, which no longer provides a broad recommendation for healthy children.
Kennedy's announcement prompted criticism from medical experts who said the health secretary circumvented the government's decision-making process on vaccines and could prevent health insurance coverage for Covid-19 shots to vulnerable Americans.
The Infectious Diseases Society of America said on Tuesday that removing the recommendation "does the opposite of what Americans have been asking for when it comes to their health - it takes away choices and will negatively impact them." It added infants and children may "develop severe disease and may suffer from prolonged symptoms due to long Covid-19, which can negatively impact their development."
[[nid:718567]]
Nearly 1,900 children up to 18 years of age died of Covid0-19 in the US, according to CDC estimates updated in 2023.
The makers of Covid-19 vaccines available in the US - Pfizer, Moderna and Novavax - did not immediately respond to requests for comment.
Traditionally, the CDC's Advisory Committee for Immunization Practices would meet and vote on changes to the immunization schedule or recommendations on who should get vaccines before the agency's director made a final call. The committee had not voted on the changes announced by Kennedy.
Last week, the FDA said it plans to require new clinical trials for approval of annual Covid-19 boosters for healthy Americans under 65, effectively limiting them to older adults and those at risk of developing severe illness.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
2 days ago
- Straits Times
People with severe diabetes in US are cured in small trial of new drug
The experimental treatment involves stem cells that scientists prodded to turn into pancreatic islet cells, which regulate blood glucose levels. PHOTO ILLUSTRATION: PEXELS People with severe diabetes in US are cured in small trial of new drug A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of Type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need much lower doses. The experimental treatment, called zimislecel and made by Vertex Pharmaceuticals of Boston, involves stem cells that scientists prodded to turn into pancreatic islet cells, which regulate blood glucose levels. The new islet cells were infused and reached the pancreas, where they took up residence. The study was presented on June 20 at the annual meeting of the American Diabetes Association and published online by The New England Journal of Medicine. 'It's trailblazing work,' said Dr Mark Anderson, professor and director of the diabetes center at the University of California, San Francisco, who was not involved in the study. 'Being free of insulin is life changing, who was not involved in the study,' he said. Vertex, like other drug companies, declined to announce the treatment's cost before the Food and Drug Administration approves it. A Vertex spokesperson said the company had data only on the population it studied so it could not yet say whether the drug would help others with Type 1 diabetes. About 2 million Americans have Type 1 diabetes, which is caused when the immune system destroys islet cells. A subset of islet cells, the beta cells, secrete insulin. Without insulin, glucose cannot enter cells. Patients with Type 1 must inject carefully calibrated doses of the hormone to substitute for the insulin their body is missing. Type 1 is different from the more common Type 2 diabetes, which usually occurs later in life. Controlling insulin levels is a constant, often costly effort. Elevated blood sugar levels can damage the heart, kidneys, eyes and nerves. But if levels fall too low, people can feel shaky, pass out or have seizures. The patients in the study are among the estimated 30 per cent with a complication of Type 1 diabetes – hypoglycemic unawareness. Those with the condition have no warning when their glucose levels are falling precipitously. They lack the normal signs like shakiness or sweating that can signal a need for glucose. Patients with hypoglycemic unawareness can suddenly pass out, have seizures or even die. It's a frightening way of life, said Dr Trevor Reichman, director of the pancreas and islet transplant program at University Health Network, a hospital in Toronto, and first author of the study. 'You worry all day, every day where your glucose is and what you eat and when you exercise,' he added. Patients in the study began to need less insulin within a few months of being infused with new islet cells, and most stopped needing the hormone altogether at about six months, Dr Reichman said. He added that patients' episodes of hypoglycemia went away within the first 90 days of treatment. If the study continues to show positive results, the company expects to submit an application to the FDA in 2026. 'For the short term, this looks promising' for severely affected patients like those in the study,' said Dr Irl B. Hirsch, a diabetes expert at the University of Washington who was not involved in the study. But patients in the trial had to stay on drugs to prevent the immune system from destroying the new cells. Suppressing the immune system, he said, increases the risk of infections and, over the long term, can increase the risk of cancer. 'The argument is this immunosuppression is not as dangerous as what we typically use for kidneys, hearts and lungs, but we won't know that definitely for many years,' Dr Hirsch said. Patients may have to take the immunosuppressant drugs for the rest of their lives, the Vertex spokesperson said. The treatment is the culmination of work that began more than 25 years ago when a Harvard researcher, Dr Doug Melton, vowed to find a cure for Type 1 diabetes. His 6-month-old boy developed the disease and, then, so did his adolescent daughter. His passion was to find a way to help them and other patients. He began, he said, with an 'unwavering belief that science can solve the most difficult problems'. It took 20 years of painstaking, repetitive, frustrating work by Dr Melton and a team of about 15 people to find the right chemical cocktail to turn stem cells into islet cells. He estimated that Harvard and others spent US$50 million (S$64 million) on the research. Dr Peter Butler, a professor of medicine at UCLA and a consultant to Vertex, said he was awed by the achievement of the Harvard team. 'The fact that it worked at all is just freaking amazing to me,' he said. 'I can guarantee there were a thousand negative experiments for every positive one.' When Dr Melton finally succeeded, he needed a company to take the discovery into the clinic. He joined Vertex, which took up the challenge. The first patient to get the experimental therapy, Mr Brian Shelton, got an infusion in 2021. He had been plagued by episodes of plummeting blood sugar that made him lose consciousness. Once he crashed his motorcycle into a wall, and another time he passed out in a yard while working his mail delivery route. The infusion cured him, but he died shortly afterward from what Vertex described as dementia symptoms that began before his treatment. Recruitment of the 12 patients in the new report proceeded slowly, Reichman said, because of the strict entry requirements. Some who qualified backed out when they heard they would have to take immunosuppressive drugs, he added. One who joined, Ms Amanda Smith, a 36-year-old nurse in London, Ontario, said she jumped at the chance to enter the trial. Six months after the infusion, she no longer needed insulin. 'It's like a whole new life,' she said. NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
3 days ago
- Straits Times
New initiative to help young people with poor mental health when ‘red flags' appear
Minister of State for Health Rahayu Mahzam (third from right) at the launch event for the new initiative. ST PHOTO: AZMI ATHNI New initiative to help young people with poor mental health when 'red flags' appear SINGAPORE – Young people with poor mental health will get more help through a programme that trains school counsellors and social workers to spot red flags and tackle distress before it escalates. The initiative launched on June 20 addresses a mental health crisis among Singapore's adolescents, which had brewed silently until the Covid-19 pandemic, said Dr Angelina Ang, a senior consultant in the emergency department of KK Women's and Children's Hospital (KKH) who heads the programme. It comes after the hospital studied patients aged 10 to 19 who had been admitted to its emergency department in 2021 for trying to harm or kill themselves. The study, published in February, found that about one in five of these adolescents had visited a hospital or polyclinic for medically unexplained physical symptoms like headaches and stomachaches within the year prior to attempting self-harm or suicide. Said Dr Ang: 'Medically unexplained symptoms are red flags – symptoms of distress, anxiety, or maybe even abuse, and if we continue to sweep them under the carpet, they will crash on the child.' Difficulties sleeping, dealing with family conflict and anxieties related to academic performance were the top challenges faced by these adolescents. More than half the patients who attempted self-harm or suicide said they were confused or unsure about whether they truly wanted to end their lives, which suggests that their decisions can be driven by impulse and inability to process their emotions. The price paid for ignoring such signs is huge, said Dr Ang, citing a 2023 report by Duke-NUS Medical School and the Institute of Mental Health estimating that the cost to treat a child for depression and anxiety here averaged $10,250. To plug these gaps, the programme developed by psychologists from KKH and James Cook University (JCU) teaches community groups how to intervene when young people display these physical symptoms and have difficulty managing emotions. Since October 2024, more than 300 school counsellors and community mental health practitioners have been trained, KKH and Temasek Foundation, said in a joint statement. Parked under the Temasek Foundation Youth Connect programme, the initiative is complemented by screening at KKH's emergency department that coordinates care for these young people with schools and communities. KKH chief executive Alex Sia said since such screening was implemented since October 2022, it has assessed more than 2,500 young people, and provided support to over 1,300 of them . In addition, Dr Ang said the collaboration between KKH and JCU is developing a programme to tackle sleep habits of the young, which is an easier topic to broach than mental health. The programme remains in the works, but the team has started training community groups and professionals to deliver these interventions. Minister of State for Health Rahayu Mahzam said at the launch event at KKH that the Youth Connect Programme allows for a seamless care system that can minimise the risk of young people falling through the cracks. She added: 'Today's launch is more than just a new programme for mental health support. 'It represents our collective commitment – regardless of our area of work – to support young people that we meet, in ways that best suit them.' The programme joins a nationwide push for more to be done to address the mental health crisis plaguing Singapore's teens, with one in three young people reporting severe symptoms of depression, anxiety or stress, according to a recent nationwide survey. Mental disorders are the leading cause of disability and death among those aged 10 to 14 in Singapore, according to a study published in The Lancet Public Health medical journal in May. The study also ranked Singapore top in Asean for the impact of mental distress on its population. Despite many of Singapore's adolescents reporting signs of mental distress, a nationwide study of youth mental health by the National University of Singapore flagged a gap in their parent's understanding of the issues that their children faced. The study released in 2023 found that only about one in 10 parents observed signs of distress in their children, despite one in three reporting symptoms like depression and anxiety. Helplines Mental well-being Institute of Mental Health's Mental Health Helpline: 6389-2222 (24 hours) Samaritans of Singapore: 1-767 (24 hours) / 9151-1767 (24 hours CareText via WhatsApp) Singapore Association for Mental Health: 1800-283-7019 Silver Ribbon Singapore: 6386-1928 Chat, Centre of Excellence for Youth Mental Health: 6493-6500/1 Women's Helpline (Aware): 1800-777-5555 (weekdays, 10am to 6pm) Counselling Touchline (Counselling): 1800-377-2252 Touch Care Line (for caregivers): 6804-6555 Counselling and Care Centre: 6536-6366 We Care Community Services: 3165-8017 Clarity Singapore: 6757-7990 Online resources (for those aged 13 to 25) (for those aged 12 to 25) Join ST's WhatsApp Channel and get the latest news and must-reads.
Straits Times
3 days ago
- Straits Times
Malaysia records first Covid-19 death of 2025
To date, a total of 21,738 Covid-19 cases have been recorded. PHOTO: AFP PETALING JAYA - Malaysia has recorded its first Covid-19 death in 2025. The Health Ministry said that the death occurred during Epidemiological Week 24, that spanned from June 8 to June 15. 'The individual had serious comorbidities, which were heart disease and diabetes, with the deceased also not taking the second booster vaccine shot,' the ministry said in a statement on June 19. The ministry added that this was a drastic drop compared to the 57 deaths in 2024. 'The last Covid-19 related death was recorded on May 26, 2024. This shows the effective control steps taken by the ministry,' it said. It added that six Covid-19 cases had been admitted to ICU wards with patients suffering from comorbidities. 'All cases were closely monitored with care, with all patients discharged from ICU wards. Four were allowed to return home, with two transferred to normal wards,' it said. To date, a total of 21,738 Covid-19 cases have been recorded. 'However, there has been an increase in Week 24 with 3,379 cases compared to the 2,011 cases recorded during the prior week. This is a 68 per cent increase,' it said, adding that the situation remains controlled. THE STAR/ASIA NEWS NETWORK Join ST's Telegram channel and get the latest breaking news delivered to you.
